Gilead Sciences said multiple Canadian provinces will provide access to the biotechnology company's hepatitis C drug Harvoni following a positive reimbursement recommendation from regulators.
Mar 24, 2015
0
3
For more than 25 years, Richard Huganir, Ph.D., Bloomberg Distinguished Professor of Neuroscience and Psychological and Brain Sciences and director of the Solomon H. Snyder Department of Neuroscience, at the Johns Hopkins ...
Oct 13, 2023
0
75
A research team led by Hong Kong Baptist University (HKBU) has identified a molecular target for bone anabolic therapies using a selected aptamer that serves as an inhibitor of sclerostin, a protein that prevents bone growth. ...
Dec 19, 2022
0
69
Moderna plans to have 100 to 125 million doses of its COVID-19 vaccine available in the first quarter of 2021, the vast majority of which will go to the United States, the biotechnology company announced Thursday.
Dec 4, 2020
0
2
A team of researchers at the University of Georgia are developing and testing new vaccines and immunotherapies to combat the novel coronavirus that has infected hundreds of thousands across the world.
Mar 25, 2020
0
3
Scientists from the National University of (NUS) have discovered a novel low-cost method of testing for cancers. Called the Heatrich-BS assay, this new test sequences clinical samples that have been heated in order to isolate ...
Dec 5, 2022
0
133
Irish biotechnology company Elan rejected on Monday the latest takeover bid from US group Royalty Pharma worth about $7.9 billion (6.0 billion euros).
Jun 10, 2013
0
0
Georgetown University Medical Center (GUMC) has licensed worldwide rights of a potential novel cancer therapy and diagnostic, or "theranostic," to BioMetrx, LLC. The agent was invented by two Georgetown researchers.
Jan 24, 2012
0
0
Researchers have successfully tested treatments for people with allergies to grasses and to dust mites.
Oct 3, 2013
0
0
In late July there were reports in the media from a conference in Chicago about Alzheimer's disease. The focus of journalists' attention was a new study of how the progression of the disease is affected by the BAN2401 antibody, ...
Oct 19, 2018
0
3
